Form 8-K - Current report:
SEC Accession No. 0001193125-23-276021
Filing Date
2023-11-13
Accepted
2023-11-13 16:11:15
Documents
13
Period of Report
2023-11-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d312014d8k.htm   iXBRL 8-K 24504
  Complete submission text file 0001193125-23-276021.txt   181171

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20231109.xsd EX-101.SCH 3878
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20231109_def.xml EX-101.DEF 13653
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20231109_lab.xml EX-101.LAB 22565
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20231109_pre.xml EX-101.PRE 14621
7 EXTRACTED XBRL INSTANCE DOCUMENT d312014d8k_htm.xml XML 5303
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 231398798
SIC: 2834 Pharmaceutical Preparations